GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SLS BIO Co Ltd (XKRX:246250) » Definitions » Gross Margin %

SLS BIO Co (XKRX:246250) Gross Margin % : 27.66% (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is SLS BIO Co Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. SLS BIO Co's Gross Profit for the three months ended in Mar. 2024 was ₩567 Mil. SLS BIO Co's Revenue for the three months ended in Mar. 2024 was ₩2,048 Mil. Therefore, SLS BIO Co's Gross Margin % for the quarter that ended in Mar. 2024 was 27.66%.


The historical rank and industry rank for SLS BIO Co's Gross Margin % or its related term are showing as below:

XKRX:246250' s Gross Margin % Range Over the Past 10 Years
Min: 21.93   Med: 31   Max: 39.16
Current: 29.64


During the past 9 years, the highest Gross Margin % of SLS BIO Co was 39.16%. The lowest was 21.93%. And the median was 31.00%.

XKRX:246250's Gross Margin % is ranked worse than
74.41% of 211 companies
in the Medical Diagnostics & Research industry
Industry Median: 45.55 vs XKRX:246250: 29.64

SLS BIO Co had a gross margin of 27.66% for the quarter that ended in Mar. 2024 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for SLS BIO Co was 1.70% per year.


SLS BIO Co Gross Margin % Historical Data

The historical data trend for SLS BIO Co's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SLS BIO Co Gross Margin % Chart

SLS BIO Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only 38.77 25.81 26.44 39.16 34.48

SLS BIO Co Quarterly Data
Sep22 Dec22 Jun23 Sep23 Dec23 Mar24
Gross Margin % Get a 7-Day Free Trial 41.15 - 24.69 35.54 27.66

Competitive Comparison of SLS BIO Co's Gross Margin %

For the Diagnostics & Research subindustry, SLS BIO Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SLS BIO Co's Gross Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, SLS BIO Co's Gross Margin % distribution charts can be found below:

* The bar in red indicates where SLS BIO Co's Gross Margin % falls into.



SLS BIO Co Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

SLS BIO Co's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=3111.5 / 9023.399
=(Revenue - Cost of Goods Sold) / Revenue
=(9023.399 - 5911.933) / 9023.399
=34.48 %

SLS BIO Co's Gross Margin for the quarter that ended in Mar. 2024 is calculated as


Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=566.6 / 2048.418
=(Revenue - Cost of Goods Sold) / Revenue
=(2048.418 - 1481.824) / 2048.418
=27.66 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


SLS BIO Co  (XKRX:246250) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

SLS BIO Co had a gross margin of 27.66% for the quarter that ended in Mar. 2024 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


SLS BIO Co Gross Margin % Related Terms

Thank you for viewing the detailed overview of SLS BIO Co's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


SLS BIO Co (XKRX:246250) Business Description

Traded in Other Exchanges
N/A
Address
Gwanggyo Central Biz Tower, 7th floor, Changryong-dong 260, Gyeonggi-do, Suwon-si, KOR, 16229
SLS BIO Co Ltd is engaged in providing drug development supporting services and pharmaceutical product QC through general tests and assays and instrumental analysis.

SLS BIO Co (XKRX:246250) Headlines

No Headlines